Dermatologic Oncology - MD Anderson Cancer Center
Dermatology
Dr. Madeleine Duvic, MD
|
|
Give Review
Madeleine Duvic, MD is an expert in the field of Dermatology. He researched medicine at Duke University School of Medicine. Duke University School of Medicine is a top medical university. Duke University School of Medicine is ranked 8/29 in Research/PrimaryCare. He received 5 awards: "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer", "Super Doctor" and "Fellow (FAAD)". Madeleine Duvic is a published physician. He published 100 publications, including: 'BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.' Madeleine Duvic accepts Medicare payments and is registered with Medicare.gov.
Publications
- A Single-Center Experience With Brentuximab Vedotin in Gamma Delta T-Cell Lymphoma.
- Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
- Genomic profiling of Sézary syndrome identifies alterations of key T Cell signaling and differentiation genes.
- Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients.
- Verrucous presentation in patients with mycosis fungoides.
- Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
- Shared clonality in distinctive Lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin.
- The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T Cells in patients with leukemic cutaneous T-Cell ly...
- Advanced-Stage Mycosis Fungoides and Sézary Syndrome: Survival and Response to Treatment.
- Characteristics of Sweet Syndrome in Patients With Acute Myeloid Leukemia.
- T-Cell Receptor-γ in Gamma-Delta Phenotype Cutaneous T-Cell Lymphoma Can Be Accompanied by Atypical Expression of CD30, CD4, or TCRβF1 and an Indolent Clinical Course.
- Low-dose total Skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 pha...
- Stenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta T-Cell lymphoma.
- Reduction of Regulatory T Cells by Mogamulizumab, a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients with Aggressive/Refractory Mycosis Fungoides and S...
- A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-Cell lymphoma.
- Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome.
- Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: A case series of 34 patients.
- Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-Cell lymphoma.
- Histological features associated with vemurafenib-induced Skin toxicities: examination of 141 cutaneous lesions biopsied during therapy.
- Vitamin D Deficiency in Mycosis Fungoides and Sézary Syndrome Patients Is Similar to Other Cancer Patients.
- 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous Melanoma: a case-control analysis.
- Multiple Skin-Colored Papules With Diffuse Sclerosis.
- Interferon-Based Treatment for Patients with Mycosis Fungoides and Hepatitis C Virus Infection: A Case Series.
- Concurrent chronic lymphocytic leukemia and cutaneous T Cell lymphoma: a case series.
- Pralatrexate Alone or in Combination With Bexarotene: Long-Term Tolerability in Relapsed/Refractory Mycosis Fungoides.
- Alopecia areata after HLA-identical BMT from an affected, sibling donor.
- Results of an open-label multicenter phase II trial of lenalidomide monotherapy in refractory mycosis fungoides and Sezary syndrome.
- The national alopecia areata registry-update.
- Development of the alopecia areata symptom impact scale.
- Health-Related Quality of Life (HRQoL) in Alopecia Areata Patients-A Secondary Analysis of the National Alopecia Areata Registry Data.
- Sweet syndrome following vemurafenib therapy for recurrent cholangioCarcinoma.
- Blastic Plasmacytoid Dendritic Cell Neoplasm: Evolving Insights in an Aggressive Hematopoietic Malignancy With a Predilection of Skin Involvement.
- Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-Cell lymphoma.
- CD8-positive ("type D") lymphomatoid papulosis and its differential diagnosis.
- Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK.
- Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-Cell lymphomas: a clinicopathologic study of three cases.
- A case of invisible leukemic cutaneous T???Cell lymphoma with a regulatory T???Cell clone.
- Duration of Response in Cutaneous T-Cell Lymphoma Patients Treated With Denileukin Diftitox: Results From 3 Phase III Studies.
- Pediatric subcutaneous panniculitis-like T-Cell lymphoma with features of hemophagocytic syndrome.
- Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse Skin reactions.
- Analysis of dermatologic events in vemurafenib-treated patients with Melanoma.
- Augmentation of blood dendritic Cells by extracorporeal photopheresis in patients with leukemic cutaneous T-Cell lymphoma and graft-versus-host disease.
- Papuloerythroderma of Ofuji associated with an indolent CD3(-), CD4(+), TCR(-) peripheral T-Cell lymphoma.
- Primary cutaneous follicle center lymphoma following deep brain stimulation implants.
- Hydrochlorothiazide and cutaneous T Cell lymphoma: Prospective analysis and case series.
- Clinically meaningful reduction in pruritus in patients with cutaneous T-Cell lymphoma treated with romidepsin.
- Topical chemotherapy in cutaneous T-Cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechloret...
- Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-Cell lymphoma: results of a phase II trial.
- Mycosis fungoides following Skin trauma.
- Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-Cell lymphoma.
- Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sezary Syndrome from 1982 to 2009.
- Changes in Tumor Morphology and Cyclin-Dependent Kinase Inhibitor Expression in Metastatic Melanoma Treated With Selective Second-Generation BRAF Inhibitor.
- Prevalence and severity of pruritus in cutaneous T Cell lymphoma.
- Bi-clonal, multifocal primary cutaneous marginal zone B-Cell lymphoma: report of a case and review of the literature.
- Annular plaques: An unusual manifestation of graft-versus-host disease.
- Increased Twist expression in advanced stage of mycosis fungoides and Sézary syndrome.
- Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies.
- Pilot Study of Denileukin Diftitox Alternate Dosing Regimen in Patients With Cutaneous Peripheral T-Cell Lymphomas.
- HDAC inhibitors for the treatment of cutaneous T-Cell lymphomas.
- Guidelines of care for the management of primary cutaneous Melanoma.
- Primary Cutaneous Small- to Medium-Sized CD4+ Pleomorphic T-Cell Lymphoma: A Retrospective Case Series and Review of the Provisional Cutaneous Lymphoma Category.
- CD30+ Neoplasms of the Skin.
- European Organization for Research and Treatment of Cancer (EORTC), International Society of Cutaneous Lymphoma (ISCL) and United States Cutaneous Lymphoma Consortium ...
- Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-Cell lymphoma.
- Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the Uni...
- Predictors of complete responses with denileukin diftitox in cutaneous T-Cell lymphoma.
- Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab.
- Multicenter photopheresis intervention trial in early-stage mycosis fungoides.
- Sézary syndrome Cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-Cell activation by binding DC-HIL and trapping TGF-...
- In-vivo characterization of optical properties of pigmented Skin lesions including melanoma using oblique incidence diffuse reflectance spectrometry.
- Clinical roundtable monograph. The management of aggressive T-Cell lymphoma: a discussion on transformed mycosis fungoides.
- Transient iatrogenic immunodeficiency-related B-Cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
- Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).
- The spectrum of Hair loss in patients with mycosis fungoides and Sezary syndrome.
- Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous Melanoma.
- Chemoprevention of nonmelanoma Skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
- Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-Cell lymphoma.
- A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-Cell lymphoma and psor...
- Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-Cell lymphoma.
- Early-stage mycosis fungoides variants: case-based review.
- Langerhans Cell histiocytosis arising from a BCC: a case report and review of the literature.
- Curcumin selectively induces apoptosis in cutaneous T-Cell lymphoma Cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling.
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.
- Primary and metastatic malignant tumors of the scalp: an update.
- Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-Cell transplantation in advanced mycosis fungoides and Sezary syndrome.
- Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-Cell lymphoma.
- HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy.
- Efficacy and safety of topical tazarotene: a review.
- Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors.
- Attitudes of dermatologists in the southeastern United States regarding treatment of alopecia areata: a cross-sectional survey study.
- Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-Cell lymphoma.
- A phase II study of SGN-30 in cutaneous anaplastic large Cell lymphoma and related lymphoproliferative disorders.
- Transillumination as a means to differentiate melanocytic Lesions based on their vascularity.
- Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata.
- History of atopy or autoimmunity increases risk of alopecia areata.
- Sweet syndrome associated with celiac disease.
- Atypical histologic and immunohistochemical findings in melanocytic nevi after liquid nitrogen cryotherapy.
- Detection of high-risk human papillomaviruses in verrucae of patients with mycosis fungoides and Sezary syndrome: a case series.
- BRAF inhibitor therapy-associated melanocytic Lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.
Schools
Duke University School Of Medicine
Duke University
Procedures Preformed
- Adjacent Tissue Transfer
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Excision of Benign Skin Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
- Internal Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- HealthSmart
- Humana
- MagnaCare
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MHealth Insured
- National Elevator
- Planned Administration Inc
- Principal Life
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Super Doctor
- Fellow (FAAD)
Education
-
Duke University Hospital -
Duke University School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1013964105 | |
| NPPES Provider LastName | DUVIC | |
| NPPES Provider FirstName | MADELEINE | |
| NPPES Provider ZIPCode | 770301312 | |
| NPPES Provider State | TX | |
| Specialty Description | Dermatology | |
| Total Claim Count | 978.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013964105 |
| Last Name Of The Provider | DUVIC |
| First Name Of The Provider | MADELEINE |
| View All |
Similar Doctors
|
Dr. Vincent W. Kau, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leigh E. Eubanks, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mujahed M. Alikhan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shilpa Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shaun D. Smithson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas D. Nichols, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony P. Nikko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Riva L. Collins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew H. Rudolph, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer A. Hickman, MD |
|
|
Dr. Stephanie H. Aldama, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lucile E. White, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rashid Rashid, MD |
|
|
Dr. Sarah J. Seyfer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina N. Davis, MD |
|
|
Dr. Rachel M. Ellis, MD |
|
|
Dr. Isha E. Lopez, MD |
|
|
Dr. Kerri L. Robbins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy L. Carter, MD
This Doctor is OpenDoctor Recommended.
|